Multiple sulfatase deficiency (MSD) is an inherited lysosomal storage disease characterized by the deficiency of at least seven sulfatases. The basic defect in MSD is thought to be in a post-translational modification common to all sulfatases. In accordance with this concept, RNAs of normal size and amount were detected in MSD fibroblasts for three sulfatases tested. cDNAs encoding arylsulfatase A, arylsulfatase B, or steroid sulfatase were introduced into MSD fibroblasts and fibroblasts with a single sulfatase deficiency by retroviral gene transfer. Infected fibroblasts overexpressed the respective sulfatase polypeptides. While in single-sulfatasedeficiency fibroblasts a concomitant increase of sulfatase activities was observed, MSD fibroblasts expred sulfatase polypeptides with a severely diminished catalytic activity.
Multiple sulfatase deficiency (MSD) is a rare autosomal recessively transmitted lysosomal storage disorder characterized by the accumulation of sulfated lipids and carbohydrates. The disorder is caused by partial deficiencies of at least six lysosomal and one microsomal sulfatase (1) . MSD is clinically and biochemically heterogenous. On the basis of the residual activities of sulfatases, MSD patients can be classified in two groups. Patients of group I exhibit severe sulfatase deficiencies and a neonatal onset of the disease, and patients of group II show moderate sulfatase deficiencies (2) .
The primary defect in MSD is unknown. The mutations in MSD and single sulfatase deficiencies [e.g., metachromatic leukodystrophy (MLD), mucopolysaccharidosis II, IIIA, and IV, and chromosome X-linked ichthyosis] are nonallelic as shown by complementation studies (3) (4) (5) (6) . The primary defect in MSD affects the stability and the catalytic properties of sulfatases to a variable extent depending on the type of sulfatase and the MSD cell line (2, (7) (8) (9) . This led to the hypothesis that the mutations in MSD affect a gene product that interacts with sulfatases co-or post-translationally. This process-shared by all sulfatases-is thought to activate and/or stabilize the sulfatases (2, 8) .
To test this hypothesis we analyzed the expression of sulfatases in MSD fibroblasts on the RNA level and introduced the cDNAs of sulfatases into MSD fibroblasts via retroviral gene transfer. According to the working hypothesis, sulfatase genes and their transcription should be normal in MSD, while expression of the endogenous genes and of the introduced cDNAs should yield sulfatase polypeptides that are inactive and/or unstable. On the other hand, expression of the same cDNAs in cells with single sulfatase deficiencies caused by mutations in the sulfatase genes should yield sulfatase polypeptides with normal catalytic properties and stability, as was shown recently (10, 11) .
We studied the expression of two lysosomal sulfatases, arylsulfatase A (ASA) and arylsulfatase B (ASB), and the microsomal steroid sulfatase (STS). In accordance with the current hypothesis we observed normal amounts of RNA for ASA, ASB, and STS in group I MSD fibroblasts. More important, expression of the cDNAs for ASA, ASB, and STS led to the synthesis of inactive polypeptides in MSD fibroblasts and to catalytically active sulfatase polypeptides in fibroblasts from patients with a single sulfatase deficiency. Our results clearly demonstrate that the basic defect in MSD affects a co-or post-translational modification that makes sulfatase polypeptides active or prevents their inactivation.
MATERIALS AND METHODS
Cell Lines and Cell Culture. The MSD fibroblasts were obtained from J. Couchot (Clinic de Pediatrie et Puericulture, Reims) and E. Christenson (Rigshospitalet, Copenhagen). The MLD fibroblasts deficient in ASA activity, the Maroteaux-Lamy fibroblasts deficient in ASB, and the chromosome X-linked ichthyosis fibroblasts deficient in STS were obtained from R. Gitzelmann (Kinderhospital, Zurich), J. Zimmer (Humangenetik, Freiburg), and the Human Genetic Cell Repository (Lyon). The packaging cell line PA 317 (12) was kindly provided by K. Pfitzenmeyer (Klinische Forschergruppe der Max-Planck-Gesellshaft, Gottingen) and the retroviral vector pXT1 (13) by E. Wagner (Research Institute of Molecular Pathology, Vienna).
Human fibroblasts were maintained at 370C, under 5% CO2 in minimal essential medium containing 15-20% fetal calf serum. The culture medium was changed every 3-4 days. The packaging cell line PA 317 was cultured in Dulbecco's modified Eagle's medium with 10% fetal calf serum.
RNA Isolation, Northern Blot Hybridization, and Probes. Total RNA of 1-3 x 107 cultured human fibroblasts was prepared as described (14) . Total RNA in 20 gl of 20 mM morpholinopropanesulfonic acid (Mops), pH 6.8/6% formaldehyde/33% formamide was heated for 10 min to 70'C and electrophoresed through a 1.3% denaturing agarose gel containing 0.7% formaldehyde in 20 mM Mops, pH 6.8, and transferred to Hybond-N membranes (Amersham).
The radioactive probes for Northern blot analysis were prepared by the multiprime DNA labeling system (Amersham) with the ASA cDNA insert of pBEH/HT14-CP 18 (15) and the STS cDNA insert pBEH-STS (16 Production of Recombinant Retroviruses. The construction of the retroviral vectors containing the cDNAs of ASA and ASB were described previously (10, 11) . For the construct containing the coding part ofthe ASA pseudodeficiency allele (pdASA) a 1828-base-pair (bp) Xho I-Sal I DNA fragment was isolated from the eukaryotic expression vector pBEHpdASA (17) . It contains the entire cDNA for pdASA, 62 bp of 5' untranslated sequence of the ASA cDNA, and 65 bp of simian virus 40 5' untranslated sequence derived from the expression vector. This fragment was ligated into the Xho I site of the retroviral vector pXT1 (13) .
For construction of the plasmid pXT1STS a Xho I-Sal I DNA fragment from the eukaryotic expression vector pBEH-STS (16) was used. It contains the entire cDNA coding for STS and 65 bp of simian virus 40 5' untranslated sequence that is part of the expression vector. This fragment was ligated into the Xho I site of the retroviral vector pXT1.
For the production of replication-defective infectious retroviruses the vectors pXT1ASA, pXT1ASB, and pXT1STS were transfected into the helper-virus-free amphotropic packaging cell line PA 317 (12) by the calcium phosphate precipitation technique. Cells were selected with neomycin at 0.4 mg/ml. Resistant cells were recultured to about 50%o confluency. Selection was withdrawn for 2 days, and the tissue culture medium containing the retrovirus was harvested, centrifuged, filtered through a 0.45-,um-pore filter to exclude remaining packaging cells, tested for colony-forming units (cfu) on NIH 3T3 tk-cells, and stored at -80°C until used for infection of fibroblasts. Throughout this article the retroviral vectors are designated by a p (e.g., pXT1). The p will be omitted to designate the corresponding viruses (e.g., XT1 (21) and STS from the membrane fraction (16) were performed as previously described.
Indirect ELISA of ASA Protein. ASA protein contents in the different cell extracts were compared by an indirect ELISA (H. J. Sommerlade, personal communication) using affinity-purified rabbit antibodies to human ASA to coat the wells and a mouse antiserum against human ASA and goat anti-mouse IgG/IgM conjugated to horseradish peroxidase to detect ASA. Under the conditions used the assay was linear for up to 1 ,ug of ASA.
RESULTS
Sulfatase RNAs in MSD Fibroblasts. Total RNA from group I MSD and control fibroblasts was subjected to Northern blot analysis and hybridized with cDNA probes specific for ASA and STS (Fig. 1) . In total RNA of controls the ASA probe detects transcripts of 4.8, 3.7, and 2.1 kb and the STS probe isolated from the group I MSD fibroblasts (Co.) and control fibroblasts (Br.) was hybridized with an ASA cDNA probe. (Right) RNA (5 Zg) isolated from group I MSD fibroblasts (Co.), chromosome X-linked-ichthyosis fibroblasts (800), and control fibroblasts (Br.) was hybridized with an STS cDNA. The size of the RNA species is indicated in kilobases (kb). Ethidium bromide staining and rehybridization with an actin probe revealed that comparable amounts of RNA had been loaded (not shown).
detects RNA species of 6.3, 4.6, and 2.5 kb. The latter represents a minor species detectable only after prolonged exposure. In total RNA from fibroblasts carrying a deletion of the STS gene (X-linked ichthyosis), none of the STS RNA species is detectable. In total RNA from group I MSD fibroblasts, ASA and STS transcripts of the same size as in control RNA were detectable. Furthermore, the amounts of ASA and STS transcripts in MSD and control fibroblasts were comparable (shown for cell line Co. in Fig. 1 ). Recently we have reported similar findings for ASB (22) . These results show that the primary defect in MSD does not affect the transcription of ASA, ASB, and STS or the stability of their transcripts.
Retroviral Gene Transfer Does Not Restore Sufatae Activities in MSD Fibroblasts. We introduced the sulfatase cDNAs into human diploid fibroblasts by infection with recombinant retroviruses. cDNA fragments containing the coding sequences of human ASA, ASB, and STS were cloned in the retroviral expression vector pXT1 (10, 11) , yielding the plasmids pXT1ASA, pXT1ASB, and pXT1STS (Fig. 2) . The cDNA is under the control of the promoter from the herpes simplex virus thymidine kinase gene. The neomycin resistance gene, which in eukaryotes confers resistance to the antibiotic Geneticin, is expressed from the Moloney murine leukemia virus 5' long terminal repeat of the vector (13) .
Two group I MSD cell lines (Co. and Mo.) were infected with the virus XT1ASA. Infected fibroblasts exhibited ASA activities that were not significantly different from controls that were mock infected or infected with the parent retrovirus XT1 (Table 1) . To control for the ability of the XT1ASA virus stock to introduce the ASA gene into fibroblasts we infected in parallel fibroblasts from two patients with MLD (2301 and Proc. NatL Acad Sci. USA 89 (1992) La.). Both MLD cell lines lack ASA mRNA and ASA activity due to homozygosity for a splice donor site mutation of ASA exon 2 (23) . Infection of these two MLD cell lines with XT1ASA retrovirus and subsequent selection yielded cells with ASA activities about 10-fold higher than normal fibroblasts (Table 1) .
Experiments similar to those with the ASA cDNAtransferring virus were done with viruses transferring the cDNAs for ASB and STS. The capacity of the recombinant viruses XT1ASB and XT1STS to restore either ASB or STS activity in deficient fibroblasts was examined by infection of fibroblasts with a deficiency of ASB (Maroteaux-Lamy syndrome/mucopolysaccharidosis type VI) or STS (X-linked ichthyosis). The ASB activity in infected Maroteaux-Lamy fibroblasts was up to 20-fold higher than in normal fibroblasts (Table 2) , and the STS activity in infected X-linked ichthyosis fibroblasts was up to 12-fold higher (Table 3) . Infection of group I MSD fibroblasts with XT1ASB slightly increased the residual ASB activity, but not to the level found in normal fibroblasts (Table 2) . Infection with XT1STS did not increase the residual STS activity in the MSD fibroblasts (Table 3) . It is apparent from these results that retrovirus-mediated gene transfer cannot restore sulfatase activities to normal levels, (Fig. 3) (Table 1) . To follow the synthesis of ASA polypeptides, infected control, MLD, and MSD fibroblasts were labeled for 16 hr with [35S]methionine. Incorporation of radioactivity into trichloroacetic acid-insoluble material was comparable in all cell lines. In MSD and MLD cells infected with the ASA-or pdASA-carrying retroviruses the amount of [35S]ASA polypeptides was 5-to 7-fold higher than in control fibroblasts infected with the parent virus XT1. In MSD and MLD cells infected with XT1pdASA the ASA polypeptides were 2.5 kDa smaller. MLD fibroblasts infected with XT1 lacked ASA polypeptides, and MSD fibroblasts infected with XT1 contained reduced amounts (about 40% of control) of normalsized ASA polypeptides (Fig. 4) . This clearly indicates that in cells infected with the ASA-or pdASA-carrying retroviruses the bulk of ASA polypeptides are expressed from the retrovirally transferred ASA cDNAs and that the efficiency of expression is similar in MSD and MLD fibroblasts.
When MSD and MLD fibroblasts expressing pdASA polypeptides were cultured with unlabeled methionine after the metabolic labeling for up to 14 days, the [35S]ASA polypeptides decreased at comparable rates in the two cell types (t1/2 of approximately 12 days; data not shown). The apparent stability of ASA polypeptides expressed from retrovirally transferred ASA cDNAs is therefore comparable in MSD and MLD fibroblasts.
A comparison of the ASA activity and the amount of radioactivity incorporated into ASA in the cell lysates shown in Fig. 4 suggests that catalytically inactive ASA polypeptides are synthesized in MSD fibroblasts. The ratio of ASA activity and 3S radioactivity in ASA polypeptides in MSD fibroblasts is less than 1/20th of that in control and MLD fibroblasts. To obtain a more precise estimate for the specific activity ofASA we quantified the ASA crossreacting material by an ELISA and compared it to the ASA enzyme activity ( Table 4 Contror(Ki.), MLD (2301), and MSD (Co.) fibroblasts infected with retrovirus XT1, XT1ASA, or XT1pdASA were metabolically labeled as described for Fig. 3 . ASA-specific polypeptides are indicated by arrows. The apparent size of the ASA polypeptides encoded by the pdASA lacking the third potential N-glycosylation site is 2.5 kDa smaller than normal ASA. Below the lanes the radioactivity incorporated into ASA polypeptides and the ASA activity in cell extracts are given. was 59 U/mg of ASA. This agrees with the specific activities of 30 and 64 U/mg that have been reported for ASA purified from human placenta and human urine (24) (25) (26) (27) . The specific activity of ASA and pdASA expressed in MLD cells was in the same range (63-78 U/mg), while it was less than 1/20th as high in group I MSD cells (2-3 U/mg).
DISCUSSION
Retroviral infection is an effective means to restore the sulfatase deficiencies in fibroblasts with a single deficiency of ASA, ASB, or STS (this study; refs. 10 and 11). In this study we show that infection of group I MSD fibroblasts with the same viral stocks fails to restore the deficient sulfatase activities. The transferred cDNAs led to an overexpression of sulfatase polypeptides but-as examined in detail for ASAthe catalytic activity of these polypeptides was greatly reduced. These observations strongly suggest that the basic defect in MSD affects a co-or post-translational process that controls the catalytic properties of sulfatases.
A defect in the editing of sulfatase RNAs is one of the mechanisms that could explain the phenotype of MSD. The colinearity of the nucleotide sequence of the ASA RNA and of the ASA gene (ref. 28 ; V. Gieselmann, personal communication) has made it unlikely that sulfatase RNAs are subject to a common editing step. If sulfatase RNAs would require editing to code for catalytically active sulfatases and if this would be defective in MSD, sulfatase cDNAs, which derive from edited RNAs, introduced into MSD fibroblasts should encode catalytically active sulfatases. The failure to express catalytically active sulfatases from three different sulfatase cDNAs as observed in this study excludes the possibility that the primary defect in MSD affects the editing of sulfatases.
In earlier studies a decreased stability of endogenous ASA and ASB polypeptides had been observed (2, 7) . In the present study, using in part the same cell lines (e.g., MSD cell line Co.), we made several observations that are incompatible with a significantly decreased stability of ASA. The amount of ASA polypeptides and the apparent rate of ASA synthesis in noninfected MSD cell lines were about half normal. Furthermore, the stability ofpulse-labeled ASA polypeptides followed during a chase for up to 14 days was not decreased in MSD fibroblasts. It has been noted earlier that the residual activity of sulfatases fluctuates greatly in MSD fibroblasts and can be affected by cell culture variables (29, 30) . It is conceivable that such variables also affect the stability of sulfatase polypeptides in MSD fibroblasts.
Proc. Natl. Acad Sci. USA 89 (1992) - The specific activity (catalytic activity per mass ofenzyme) of ASA is significantly lower in MSD fibroblasts. This is true for the ASA polypeptides encoded by the endogenous ASA gene, which have 1/5th to 1/10th the specific activity, and for the ASA polypeptides encoded by the retrovirally introduced ASA cDNA. Interestingly, the specific activity of the latter was even lower, reaching only 3-6% of control values. Inactivity of ASA encoded by normal ASA cDNA can result from the absence of a co-or post-translational modification that renders ASA polypeptides catalytically active or prevents their premature inactivation. The observation that overexpression of ASA polypeptides in MSD fibroblasts is associated with even further decrease of their specific activity indicates that this modification is saturable in MSD.
The inactivity of sulfatase polypeptides could also be caused by a mutation that generates a mechanism by which sulfatases are inactivated. Such a mutation, however, would be expected to have a dominant effect. Moreover, overexpression of sulfatases in cells with such a mutation should either not affect the residual specific activity of sulfatases or increase it (due to saturation), but it should not decrease it, as was observed.
The nature of the modification that renders ASA polypeptides active or prevents their inactivation is not clear. It could consist in a covalent (stable or transient) modification. Alternatively, it may be represented by a transient interaction with a gene product controlling the folding and assembly of sulfatases. The availability of cells that overexpress sulfatases with the phenotypic defect characteristic of MSD should facilitate the identification of this modification.
